Publications by authors named "Guanglei Yu"

Claim this Profile
M
Maintenance of long-term efficacy with continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2.
Maryanne Senna, Arash Mostaghimi, Rodney Sinclair, Manabu Ohyama, Chiara Chiasserini, Guanglei Yu, Chunyuan Liu

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MFF-HPO: Protein-Phenotype Associations Prediction Based on Sequence Using Multi-Feature Fusion.
Xuehua Bi, Zhuocheng Ji, Linlin Zhang, Guanglei Yu, Zhipeng Gao

J Comput Biol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding eyebrow and eyelash involvement in patients with alopecia areata and responsiveness to treatment with baricitinib.
Arash Mostaghimi, Brittany Craiglow, Brett King, Jerry Shapiro, Justin Ko, Guanglei Yu

Br J Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 study.
Miguel Regueiro, Monika Fischer, Peter Bossuyt, Marijana Protic, Kristina Traxler, Guanglei Yu, Huaiyu Zang

J Crohns Colitis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CATH-ddG: towards robust mutation effect prediction on protein-protein interactions out of CATH homologous superfamily.
Guanglei Yu, Xuehua Bi, Teng Ma, Yaohang Li, Jianxin Wang

Bioinformatics· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bowel Urgency in Crohn's Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study.
Vipul Jairath, Geert D'Haens, Bruce E Sands, Simon Travis, María Chaparro, Guanglei Yu

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continued treatment with baricitinib results in meaningful scalp responses among scalp non-responder patients with eyebrow/eyelash regrowth in the first year.
Arash Mostaghimi, Matthias Augustin, Kazutoshi Harada, Maryanne Senna, Yves Dutronc, Guanglei Yu

J Eur Acad Dermatol Venereol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPOseq: a deep ensemble model for predicting the protein-phenotype relationships based on protein sequences.
Kai Zhao, Zhuocheng Ji, Linlin Zhang, Na Quan, Yuheng Li, Guanglei Yu

BMC Bioinformatics· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 Study.
Scott D Lee, Severine Vermeire, Ryan Ungaro, Aisha Vadhariya, Frederick Durand, Guanglei Yu

Am J Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrochemical insights into spatiotemporal characteristics of groundwater salinization and health risk assessment of fluoride in the south bank of Yellow River irrigation area, Northwest China.
Muhan Li, Shen Qu, Guanglei Yu, Yansong Bai, Xu Yang, Zeyuan Liu, Ruihong Yu

Environ Geochem Health· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of down-titration in patients with severe scalp alopecia areata initially treated with baricitinib 4-mg: Week 152 data from BRAVE-AA2.
Brett King, Manabu Ohyama, Maryanne Senna, Jerry Shapiro, Yves Dutronc, Chunyuan Liu, Guanglei Yu

J Am Acad Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib.
Brittany Craiglow, Yang Won Lee, Sergio Vañó-Galván, Alexander Egeberg, Yves Dutronc, Guanglei Yu, Yun-Fei Chen

Dermatol Ther (Heidelb)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies.
Arash Mostaghimi, Justin Ko, Antonella Tosti, Amy McMichael, Manabu Ohyama, Guanglei Yu, Yun-Fei Chen

J Am Acad Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical Trial.
Brett King, Justin Ko, Ohsang Kwon, Sergio Vañó-Galván, Bianca Maria Piraccini, Guanglei Yu, Chunyuan Liu

JAMA Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib.
Brittany Craiglow, Yang Won Lee, Sergio Vañó-Galván, Alexander Egeberg, Yves Dutronc, Guanglei Yu, Yun-Fei Chen

Dermatol Ther (Heidelb)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DDAffinity: predicting the changes in binding affinity of multiple point mutations using protein 3D structure.
Guanglei Yu, Qichang Zhao, Xuehua Bi, Jianxin Wang

Bioinformatics· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review.
Alexander Egeberg, Louise Linsell, Erin Johansson, Frederick Durand, Guanglei Yu

Dermatol Ther (Heidelb)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata: A Pooled Analysis of the BRAVE-AA1 and BRAVE-AA2 Trials.
Justin M Ko, Tiffany T Mayo, Wilma F Bergfeld, Yves Dutronc, Guanglei Yu

JAMA Dermatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matching within a hybrid RCT/RWD: framework on associated causal estimands.
Junjing Lin, Guanglei Yu, Margaret Gamalo

J Biopharm Stat· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
Ohsang Kwon, Maryanne M Senna, Rodney Sinclair, Taisuke Ito, Yves Dutronc, Guanglei Yu

Am J Clin Dermatol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting disease genes based on multi-head attention fusion.
Linlin Zhang, Dianrong Lu, Xuehua Bi, Kai Zhao, Guanglei Yu

BMC Bioinformatics· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
Brett King, Manabu Ohyama, Ohsang Kwon, Abraham Zlotogorski, Justin Ko, Guanglei Yu

N Engl J Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction and risk stratification from hospital discharge records based on Hierarchical sLDA.
Guanglei Yu, Linlin Zhang, Ying Zhang, Jiaqi Zhou, Tao Zhang

BMC Med Inform Decis Mak· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Power priors with entropy balancing weights in data augmentation of partially controlled randomized trials.
Guanglei Yu, Yuanyuan Bian, Margaret Gamalo

J Biopharm Stat· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study.
Brett King, Justin Ko, Seth Forman, Manabu Ohyama, Natasha Mesinkovska, Guanglei Yu

J Am Acad Dermatol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis